Newsbot

Cigna (CI) Reports Q4 Earnings: What Key Metrics Have to Say

The headline numbers for Cigna (CI) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Flex (FLEX) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Flex (FLEX) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Is Chewy (CHWY) a Buy as Wall Street Analysts Look Optimistic?

According to the average brokerage recommendation (ABR), one should invest in Chewy (CHWY). It is debatable whether this highly sought-after metric is effective because Wall Street analysts recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Is Tutor Perini (TPC) a Buy as Wall Street Analysts Look Optimistic?

Based on the average brokerage recommendation (ABR), Tutor Perini (TPC) should be added to ones portfolio. Wall Street analysts overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Is DraftKings (DKNG) a Buy as Wall Street Analysts Look Optimistic?

According to the average brokerage recommendation (ABR), one should invest in DraftKings (DKNG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Eaton (ETN) Is Considered a Good Investment by Brokers: Is That True?

According to the average brokerage recommendation (ABR), one should invest in Eaton (ETN). It is debatable whether this highly sought-after metric is effective because Wall Street analysts recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Exclusive-Hims and Hers Health launches compounded copy of Wegovy pill at $49

NEW YORK, Feb 5 (Reuters) - Online telehealth company Hims and Hers Health will begin offering compounded copies of Novo Nordisks new Wegovy pill at an introductory price of $49 per month, the company said Thursday, about $100 less than the brand name. Shares of Novo extended losses in early morning ?trading, and were off 6% after the news.

Pure Storage partner programme evolution reinforces commitment to 100% partner go-to-market strategy

Pure Storage, an IT pioneer delivering advanced data storage technology and services, has announced updates to its reseller, managed services and distributor programmes to create a more differentiated, solutions-led partner experience, including deeper enablement and new programme tiers. “The evolution of our partner programme builds on the foundational updates we introduced last year, reflecting Pure’s […]

London Stock Exchange (LSE) Outperform

NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für London Stock Exchange mit einem Kursziel von 13400 Pence auf "Outperform" belassen. Das starke Quartal der Tochter Tradeweb unterstreiche die Diversifizierung der Londoner, schrieb ...

Wadephul: Risiko bei kritischen Mineralien dritteln

BANDAR SERI BEGAWAN (dpa-AFX) - Außenminister Johann Wadephul peilt angesichts der Anstrengungen für mehr Unabhängigkeit von China mittelfristig eine Dreiteilung bei der Versorgung mit kritischen Rohstoffen an. Es müsse das Ziel sein, "dass wir etwa ...

Verkehrsminister wollen zu Schutz für Bahnpersonal beraten

MÜNCHEN/LANDSTUHL (dpa-AFX) - Nach dem tödlichen Angriff auf einen Zugbegleiter in Rheinland-Pfalz wollen die Verkehrsminister der Länder über mehr Schutz für Mitarbeiter im Nahverkehr beraten. Das kündigte der Vorsitzende der Ministerkonferenz, Baye...

ROUNDUP: USA und Russland wollen Militärdialog wieder aufnehmen

ABU DHABI (dpa-AFX) - Die USA und Russland haben die Wiederaufnahme ihres seit 2021 unterbrochenen Dialogs hochrangiger Militärs vereinbart. Das teilte das Kommando der US-Streitkräfte in Europa nach Verhandlungen zwischen Russen und Amerikanern in A...

RATIONAL Overweight

LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Rational von 848 auf 890 Euro angehoben und die Einstufung auf "Overweight" belassen. Die Jahresbilanz dürfte die Anleger hinsichtlich der Wachstumsdynamik und Profitabilität ...

Target bets on beauty makeover as Ulta exit looms

Target has been trying to cover up years of uneven performance, much like a rushed makeup routine that conceals flaws without fully addressing what lies beneath. Sales declines, shrinking foot traffic, and lost market share to competitors have weighed on the retailer, compounded by ...

ROUNDUP 2: EZB geht mit stabilen Leitzinsen in ein unsicheres Jahr

(neu: Mit Einschätzungen von Ökonomen) FRANKFURT (dpa-AFX) - Die Europäische Zentralbank (EZB) tastet die Leitzinsen auch im neuen Jahr zunächst nicht an. Der für Banken und Sparer wichtige Einlagenzins bleibt bei 2,0 Prozent, wie die Notenbank i...

Sandvik provides proforma numbers for Machining and Intelligent Manufacturing

In conjunction with Sandvik’s Capital Markets Day on May 20, 2025, Sandvik announced an updated Group structure effective as of January 1, 2026. Following the establishment of two new business areas through the separation of Machining and Intelligent Manufacturing, Sandvik is now publishing proforma figures for each new business area. Machining[1)]MSEK 2025 2025 2025 2025 2025 Q1 Q2 Q3 Q4 Q1-Q4Order intake ...